A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
About This Bill
Floor Vote
Latest Action · June 28, 2019
Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.